Roche's Lunsumio VELO gets FDA accelerated approval for lymphoma
Roche's Lunsumio VELO gets FDA accelerated approval for lymphoma
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
GSR Launches Crypto Core3 ETF (BESO)
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Roche's Lunsumio VELO gets FDA accelerated approval for lymphoma
Berkshire's Apple sales look more like a sizing move than a lasting retreat.
China Vanke's bondholders approve plan to extend grace period, reject repayment extension
Saipem shares rise after winning $3.1 billion QatarEnergy LNG contract
Europe opens mixed; UK GDP meets expectations
HTC bets its open AI strategy to drive smartglasses sales
Harbour Energy to acquire LLOG for $3.2 billion, enters US Gulf
Rank Group reports payment fraud in Spanish operations
GSK agrees to lower drug prices for Americans in deal with US government
Defence Holdings advances with first customer contract for Project Ixian
BofA says near-term risk of forced selling by CTAs remains limited
U.S. stocks are looking to reverse an unusual December slump following a tame reading on inflation and some positive signals about artificial-intelligence...